Accelerant Holdings

ARX · NYSE

$19.77+$0.01 (+0.05%)TodayMarket closed ·
Prev close $19.76

ARX analyst rating

HoldConsensus of 10 analysts over the last 12 months. 50% rate it a buy.
  • Strong buy0
  • Buy5
  • Hold4
  • Underperform1
  • Sell0

12-month price target · 6 analysts

Average $19.33 (−2.2% downside)

Low
$17.17
Now
$19.77
High
$21.26

Upgrades and downgrades

The latest rating actions, newest first

ARX analyst upgrades, downgrades and rating actions
FirmDateActionRating
TD CowenSep 30, 2026DowngradeBuy → Hold
Raymond JamesSep 23, 2026DowngradeMarket Perform → Underperform
CitizensAug 14, 2026DowngradeMarket Outperform → Market Perform
William BlairAug 13, 2026DowngradeOutperform → Market Perform
Wells FargoJul 9, 2026MaintainsOverweight
Morgan StanleyJul 6, 2026MaintainsEqual-Weight
BMO CapitalJun 16, 2026MaintainsOutperform
Raymond JamesJun 1, 2026MaintainsOutperform
Piper SandlerMay 26, 2026MaintainsOverweight
Morgan StanleyMay 21, 2026MaintainsEqual-Weight

The case for and against

Updated Oct 18, 2026

Bull case

Accelerant Hldgs is supported by a differentiated data-driven risk exchange that links specialty underwriters with risk capital partners, creating a fee-heavy model with nearly all earnings from commissions and fees and only limited retained insurance risk. Its fundamentals look strong because premiums written on the Risk Exchange have grown by over 39% annually on a weighted-average basis since inception, total revenue rose 53.6% to $273.3 million, and Exchange Written Premium increased 15.6% to $1,138.7 million, signaling durable organic growth. The outlook is further reinforced by a broad, diversified platform across Exchange Services, MGA Operations, and Underwriting, strong traction in North America, and management’s ability to deepen third-party premium relationships, improve productivity by 24%, and support margin expansion through operating leverage.

Bear case

Accelerant Hldgs is viewed negatively because its core underwriting economics remain exposed to softer industry pricing, higher reserve pressure from economic and social inflation, and the risk that the gross loss ratio could deteriorate from the recent 51.4% level if market conditions worsen. Its growth model also depends on expanding Risk Capital Partners and retaining Members, yet increased competition for MGA underwriters and a slowdown in E&S / MGA market growth could constrain premium expansion and fee generation. Although Adjusted EBITDA rose to $66.1 million and the deal implies about 23x 2027E EPS and 11x EV/EBITDA, the stock appears largely fully valued and vulnerable to execution risks as a newly public company and to any failure of the pending take private.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.